Reference health

Phenylalanine Effects on Brain Function in Adult Phenylketonuria

https://doi.org/10.1212/wnl.0000000000011088
CiteStamped reference-health badge
46/46 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 46 checked references that resolve
resolves10.1016/S0140-6736(10)60961-0
Phenylketonuria
resolves10.1542/peds.2009-3584
Challenges and Pitfalls in the Management of Phenylketonuria
resolves10.1016/j.jpeds.2013.12.015
Neurocognitive Evidence for Revision of Treatment Targets and Guidelines for Phenylketonuria
resolves10.1016/j.ymgme.2011.08.025
Adult phenylketonuria outcome and management
resolves10.1007/s00431-014-2458-4
Management of adult patients with phenylketonuria: survey results from 24 countries
resolves10.1212/01.wnl.0000204415.39853.4a
Global and regional volume changes in the brains of patients with phenylketonuria
resolves10.1016/j.ymgme.2016.02.004
Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria
resolves10.1016/j.ymgme.2013.08.013
Neurocognitive functioning in adults with phenylketonuria: Results of a long term study
resolves10.1002/jimd.12049
Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria
resolves10.1002/jimd.12065
The neurological and psychological phenotype of adult patients with early‐treated phenylketonuria: A systematic review
resolves10.1007/s11011-018-0267-6
The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients
resolves10.1016/j.ymgme.2009.09.015
Outcomes beyond phenylalanine: An international perspective☆
resolves10.1038/nchembio.1002
Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria
resolves10.1016/S2213-8587(16)30320-5
Key European guidelines for the diagnosis and management of patients with phenylketonuria
resolves10.1038/gim.2013.157
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
resolves10.1016/S2213-8587(17)30201-2
Issues with European guidelines for phenylketonuria
resolves10.1186/s13023-020-1329-5
Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation
resolves10.1002/mds.27035
Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts
resolves10.3233/JAD-150610
Vascular Risk Factors and Cognition in Parkinson’s Disease
resolves10.1159/000446802
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study
resolves10.1007/s00415-015-7888-z
Autonomic dysfunction in subjects at high risk for Parkinson’s disease
resolves10.1016/0013-4694(86)90145-8
Electrical stimulation over the human vertebral column: which neural elements are excited?
resolves10.1002/mds.27199
Cognitive impairment in Glucocerebrosidase (GBA)‐associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles
resolves10.1006/nimg.2000.0582
Voxel-Based Morphometry—The Methods
resolves10.2214/ajr.149.2.351
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging
resolves10.1016/j.neuroimage.2008.12.008
Computing average shaped tissue probability templates
resolves10.1016/j.ymgme.2017.03.002
Neuropsychiatric comorbidities in adults with phenylketonuria: A retrospective cohort study
resolves10.1186/s13023-019-1153-y
Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data
resolves10.1017/S0033291717001398
Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria
resolves10.1016/j.ymgme.2012.10.021
Visual functions in phenylketonuria—evaluating the dopamine and long-chain polyunsaturated fatty acids depletion hypotheses
resolves10.1016/j.ymgme.2018.12.011
Neurocognitive functioning in adults with phenylketonuria: Report of a 10-year follow-up
resolves10.1186/s13023-018-0893-4
A systematic review of cognitive functioning in early treated adults with phenylketonuria
resolves10.1007/s10545-010-9253-9
High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double‐blind, placebo‐controlled, crossover trial
resolves10.1016/j.ymgme.2011.05.017
PKU: High plasma phenylalanine concentrations are associated with increased prevalence of mood swings
resolves10.1007/s10545-016-9918-0
Social‐cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU‐COBESO study
resolves10.1093/brain/awz111
Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study
resolves10.1136/jnnp-2019-320846
Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies
resolves10.1016/j.ymgme.2009.10.005
White matter pathology in phenylketonuria☆
resolves10.1007/s10545-008-0946-2
Brain dysfunction in phenylketonuria: Is phenylalanine toxicity the only possible cause?
resolves10.1371/journal.pone.0100784
Variability of CSF Alzheimer’s Disease Biomarkers: Implications for Clinical Practice
resolves10.3233/JAD-121969
Overlap between Frontotemporal Dementia and Alzheimer's Disease: Cerebrospinal Fluid Pattern and Neuroimaging Study
resolves10.1016/j.neuron.2016.07.007
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
resolves10.1016/j.ymgme.2012.08.007
A volumetric study of basal ganglia structures in individuals with early-treated phenylketonuria
resolves10.3233/JAD-2010-100678
Increased Cortical Thickness and Caudate Volume Precede Atrophy in PSEN1 Mutation Carriers
resolves10.1007/s00259-019-04324-5
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study
resolves10.1016/j.neuron.2015.09.020
Neurocognitive Architecture of Working Memory
The 1 reference without a DOI — listed, not checked
no DOI — not checkedEvans S, Daly A, Chahal S, et al. The influence of parental food preference and neophobia on children with phenylketonuria (PKU). Mol Genet Metab Rep 2018;14:10–14.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1212/wnl.0000000000011088"><img src="https://citestamp.com/citestamped/10.1212/wnl.0000000000011088/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1212/wnl.0000000000011088/badge.svg)](https://citestamp.com/citestamped/10.1212/wnl.0000000000011088)